Pharmablue

Pharmablue company information, Employees & Contact Information

Updated May 2026

Quick answer

Pharmablue is a Pharmaceutical Manufacturing company and founded in 2015. It has approximately 35 employees on record. Contact data was last refreshed in May 2026. Find Pharmablue's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

PharmaBlue is a partner "Exploitant" of innovative Pharma Companies for the marketing in France of their medicinal products which have been granted an Early Access Authorization (EAP) or a Marketing Authorization (MA). Our mission: PharmaBlue aims to contribute to a world where patients with unmet medical needs have better access to a variety of safe, effective healthcare products, and innovative treatments. PharmaBlue belongs to PharmaLex, which is a leading provider of specialized services for the pharmaceutical, biotech and MedTech industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities.

Company Details

Employees
35
Founded
-
Address
16, Place De L'iris, Tour Cb 21,la Défense,france
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Courbevoie, Île-de-France
Looking for a particular Pharmablue employee's phone or email?

Pharmablue Questions

News

JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio? - Yahoo Finance

JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio? Yahoo Finance

Sun Pharma Announces FDA Approval of Next Generation BLU-U® Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis - PR Newswire

Sun Pharma Announces FDA Approval of Next Generation BLU-U® Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis PR Newswire

Alabama’s new pharmacy law takes effect today: What it means for your prescription costs - AL.com

Alabama’s new pharmacy law takes effect today: What it means for your prescription costs AL.com

Ionis Pharma Hits Four-Year High On A 'Home Run' In Triglycerides Treatment - Investor's Business Daily

Ionis Pharma Hits Four-Year High On A 'Home Run' In Triglycerides Treatment Investor's Business Daily

AstraZeneca: A Big Pharma Blue Chip To Buy Now (NASDAQ:AZN) - Seeking Alpha

AstraZeneca: A Big Pharma Blue Chip To Buy Now (NASDAQ:AZN) Seeking Alpha

Blue Owl Leads Around $4 Billion Debt Deal for PCI Pharma - Bloomberg

Blue Owl Leads Around $4 Billion Debt Deal for PCI Pharma Bloomberg

Blue Star, Natco Pharma Among Under-The-Radar Stocks With Upside Potential: SEBI RA Mayank Singh Chandel - Stocktwits

Blue Star, Natco Pharma Among Under-The-Radar Stocks With Upside Potential: SEBI RA Mayank Singh Chandel Stocktwits

Blue Cell Therapeutics appoints highly experienced pharma and biotech executive Olav Hellebø as Chairman of the Board of Directors - Yahoo Finance

Blue Cell Therapeutics appoints highly experienced pharma and biotech executive Olav Hellebø as Chairman of the Board of Directors Yahoo Finance

Sun Pharma rises after USFDA approves next-gen Blue Light PDT device for actinic keratosis - Business Standard

Sun Pharma rises after USFDA approves next-gen Blue Light PDT device for actinic keratosis Business Standard

Blue Owl Capital supports $4bn acquisition of PCI Pharma Services - Private Equity Insights

Blue Owl Capital supports $4bn acquisition of PCI Pharma Services Private Equity Insights

Macquarie initiates outperform rating on 4 Indian pharma stocks, sees 19-35% upside. Here's why - Mint

Macquarie initiates outperform rating on 4 Indian pharma stocks, sees 19-35% upside. Here's why Mint

AIM Market Roundup: Celadon Pharma, Blue Star Capital, Synergia - The Armchair Trader

AIM Market Roundup: Celadon Pharma, Blue Star Capital, Synergia The Armchair Trader

Blue Owl backs $4bn PCI Pharma deal - Private Equity Wire

Blue Owl backs $4bn PCI Pharma deal Private Equity Wire

Trade Spotlight: How should you trade Sun Pharma, Blue Star, Hero MotoCorp, Britannia, Acutaas Chemicals,... - Moneycontrol

Trade Spotlight: How should you trade Sun Pharma, Blue Star, Hero MotoCorp, Britannia, Acutaas Chemicals,... Moneycontrol

Blue Shield of California Unveils First-of-its-Kind Model to Transform Prescription Drug Care; Save up to $500 Million on Medications Annually - Blue Shield of California | News Center

Blue Shield of California Unveils First-of-its-Kind Model to Transform Prescription Drug Care; Save up to $500 Million on Medications Annually Blue Shield of California | News Center

Will Blue Shield’s New Pharma Model Disrupt the PBM Market? - American Hospital Association

Will Blue Shield’s New Pharma Model Disrupt the PBM Market? American Hospital Association

BLUE Software - Brand Lifecycle Management Platform for the Pharmaceutical Industry - Pharmaceutical Technology

BLUE Software - Brand Lifecycle Management Platform for the Pharmaceutical Industry Pharmaceutical Technology

Crinetics drug to challenge pharma ‘Goliaths’; FDA, ARPA move to speed gene therapies - BioPharma Dive

Crinetics drug to challenge pharma ‘Goliaths’; FDA, ARPA move to speed gene therapies BioPharma Dive

FDA’s new accelerated pathway may open pharma up to risks, as well as benefits - BioPharma Dive

FDA’s new accelerated pathway may open pharma up to risks, as well as benefits BioPharma Dive

Confessions of an Advertising Writer: How I Helped Pharma Sell Antidepressants - Mad In America

Confessions of an Advertising Writer: How I Helped Pharma Sell Antidepressants Mad In America

Q4 Results Today 2025: Aurobindo Pharma, Blue Dart Express, Firstcry Among 200+ Companies To Announce Earnings - NDTV Profit

Q4 Results Today 2025: Aurobindo Pharma, Blue Dart Express, Firstcry Among 200+ Companies To Announce Earnings NDTV Profit

Blue Shield of California bypasses PBMs to slash Humira prices by 90% - pharmaphorum

Blue Shield of California bypasses PBMs to slash Humira prices by 90% pharmaphorum

Seeking new social media horizons, EMA joins mass migration from X to Bluesky - Fierce Pharma

Seeking new social media horizons, EMA joins mass migration from X to Bluesky Fierce Pharma

MAHA may take aim at pharma DTC ads - BioPharma Dive

MAHA may take aim at pharma DTC ads BioPharma Dive

Bold moves, bolder vision: A CEO’s path for innovative pharma - McKinsey & Company

Bold moves, bolder vision: A CEO’s path for innovative pharma McKinsey & Company

Blue Shield California ditches CVS for Amazon and Mark Cuban’s drug company - CNN

Blue Shield California ditches CVS for Amazon and Mark Cuban’s drug company CNN

Use of horseshoe crabs’ blue blood puts pharma groups under scrutiny - Financial Times

Use of horseshoe crabs’ blue blood puts pharma groups under scrutiny Financial Times

Blue Shield of California drops CVS Caremark in pharmacy benefit overhaul - BioPharma Dive

Blue Shield of California drops CVS Caremark in pharmacy benefit overhaul BioPharma Dive

Untangling Sarepta’s gene therapy fallout and a growing trust deficit - Fierce Pharma

Untangling Sarepta’s gene therapy fallout and a growing trust deficit Fierce Pharma

In launching epinephrine nasal spray, ARS Pharma has a 'blue sky opportunity,' analyst says - Fierce Pharma

In launching epinephrine nasal spray, ARS Pharma has a 'blue sky opportunity,' analyst says Fierce Pharma

Amylyx drug comes up short; Sanofi names new CMO - BioPharma Dive

Amylyx drug comes up short; Sanofi names new CMO BioPharma Dive

Phathom Pharmaceuticals aims to 'kick some acid' with first Voquezna campaign - Fierce Pharma

Phathom Pharmaceuticals aims to 'kick some acid' with first Voquezna campaign Fierce Pharma

Tata Investment Corp, Strides Pharma, Blue Jet Healthcare: How to trade these buzzing 3 stocks - Business Today

Tata Investment Corp, Strides Pharma, Blue Jet Healthcare: How to trade these buzzing 3 stocks Business Today

Grow Pharma Expands Grow Access Project to Blue Light Card Holders - Business of Cannabis

Grow Pharma Expands Grow Access Project to Blue Light Card Holders Business of Cannabis

Trump Demands U.S. Drug Price Cuts, Sending Pharma Shares Slumping - Supply Chain Brain

Trump Demands U.S. Drug Price Cuts, Sending Pharma Shares Slumping Supply Chain Brain

AstraZeneca cuts US drug pricing deal; FDA declares Novo plant out of compliance - BioPharma Dive

AstraZeneca cuts US drug pricing deal; FDA declares Novo plant out of compliance BioPharma Dive

FDA official’s comments spark Aurinia sell-off; Halozyme buys a biotech - BioPharma Dive

FDA official’s comments spark Aurinia sell-off; Halozyme buys a biotech BioPharma Dive

7 Best Pharmaceutical Stocks to Buy for Income | Investing - US News Money

7 Best Pharmaceutical Stocks to Buy for Income | Investing US News Money

Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond - BioSpace

Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond BioSpace

Vertex secures Alyftrek coverage in England; Merck starts Phase 3 trials of HIV drug - BioPharma Dive

Vertex secures Alyftrek coverage in England; Merck starts Phase 3 trials of HIV drug BioPharma Dive

BridgeBio Pharma Secures up to $1.25 Billion of Capital - GlobeNewswire

BridgeBio Pharma Secures up to $1.25 Billion of Capital GlobeNewswire

With deal to buy 7 Recipharm plants, private equity firm Blue Wolf plans new CDMO - Fierce Pharma

With deal to buy 7 Recipharm plants, private equity firm Blue Wolf plans new CDMO Fierce Pharma

American Society for Meningitis Prevention paints the town purple and blue for World Meningitis Day - Fierce Pharma

American Society for Meningitis Prevention paints the town purple and blue for World Meningitis Day Fierce Pharma

BridgeBio strikes drug royalty deal for cash infusion - BioPharma Dive

BridgeBio strikes drug royalty deal for cash infusion BioPharma Dive

Eli Lilly pulls Twitter ads after blue check fallout: report - Fierce Pharma

Eli Lilly pulls Twitter ads after blue check fallout: report Fierce Pharma

Horseshoe crab blood is vital for testing intravenous drugs, but new synthetic alternatives could mean pharma won’t bleed this unique species dry - The Conversation

Horseshoe crab blood is vital for testing intravenous drugs, but new synthetic alternatives could mean pharma won’t bleed this unique species dry The Conversation

Madrigal buys into GLP-1 from CSPC; Apellis wins expanded drug approval - BioPharma Dive

Madrigal buys into GLP-1 from CSPC; Apellis wins expanded drug approval BioPharma Dive

Eli Lilly issues rare apology as fake Twitter Blue account proclaims free insulin for all - Fierce Pharma

Eli Lilly issues rare apology as fake Twitter Blue account proclaims free insulin for all Fierce Pharma

Pharma colors and marketing: Typically ‘awash in blue,’ newer brand updates adopt bold hues - Endpoints News

Pharma colors and marketing: Typically ‘awash in blue,’ newer brand updates adopt bold hues Endpoints News

Blue Water buys enlarged prostate drug Entadfi from Veru for up to $100M - Fierce Pharma

Blue Water buys enlarged prostate drug Entadfi from Veru for up to $100M Fierce Pharma

Technology and Transparency: How the Pharma Supply Chain Must Adapt - Supply Chain Brain

Technology and Transparency: How the Pharma Supply Chain Must Adapt Supply Chain Brain

Bain Capital eyes $10bn healthcare buyout with exclusive bid for PCI Pharma - Private Equity Insights

Bain Capital eyes $10bn healthcare buyout with exclusive bid for PCI Pharma Private Equity Insights

Replimune drug rejected by FDA; Omega raises $647M biotech fund - BioPharma Dive

Replimune drug rejected by FDA; Omega raises $647M biotech fund BioPharma Dive

Biotech Finally Has an IPO After Months-Long Freeze - BioSpace

Biotech Finally Has an IPO After Months-Long Freeze BioSpace

Common Side Effects review: Stunning new animated series tells the story of a cure-all mushroom - New Scientist

Common Side Effects review: Stunning new animated series tells the story of a cure-all mushroom New Scientist

Gillette India, Aurobindo Pharma, Blue Dart, Bajaj Healthcare Among 205 Companies To Announce Q4 Results Today - Goodreturns

Gillette India, Aurobindo Pharma, Blue Dart, Bajaj Healthcare Among 205 Companies To Announce Q4 Results Today Goodreturns

Chair of Pharma-Funded Blue Dogs Pushes for Drug Company Protections in New NAFTA - readsludge.com

Chair of Pharma-Funded Blue Dogs Pushes for Drug Company Protections in New NAFTA readsludge.com

‘Blue-hat’ charm: Sirio Pharma gains approval for three probiotics formulations - NutraIngredients.com

‘Blue-hat’ charm: Sirio Pharma gains approval for three probiotics formulations NutraIngredients.com

'Common Side Effects' Review: Fighting Big Pharma Has Never Been Such Fun - MovieWeb

'Common Side Effects' Review: Fighting Big Pharma Has Never Been Such Fun MovieWeb

BlueWhale Bio surfaces with $18M on mission to overhaul cell therapy production - Fierce Pharma

BlueWhale Bio surfaces with $18M on mission to overhaul cell therapy production Fierce Pharma

Techdow USA and CTTQ Pharma Announce Collaboration Agreement and Launch of Fosaprepitant for Injection - Business Wire

Techdow USA and CTTQ Pharma Announce Collaboration Agreement and Launch of Fosaprepitant for Injection Business Wire

9 Big Pharmaceutical Stocks Sporting Stellar Yields - Kiplinger

9 Big Pharmaceutical Stocks Sporting Stellar Yields Kiplinger

In silico techniques – a JPAG event - European Pharmaceutical Review

In silico techniques – a JPAG event European Pharmaceutical Review

Blue-blooded crabs at heart of pharma dispute on drug testing - Reuters

Blue-blooded crabs at heart of pharma dispute on drug testing Reuters

Bioniche Pharma and Synerx Launch Isosulfan Blue Injection 1% - PR Newswire

Bioniche Pharma and Synerx Launch Isosulfan Blue Injection 1% PR Newswire

Merck KGaA puts devices to work against diabetes in Blue Mesa digital program - Fierce Pharma

Merck KGaA puts devices to work against diabetes in Blue Mesa digital program Fierce Pharma

The Viagra effect: Sales of Lilly's ED drug Cialis slide after little blue pill goes generic - Fierce Pharma

The Viagra effect: Sales of Lilly's ED drug Cialis slide after little blue pill goes generic Fierce Pharma

OTC Viagra: Pfizer snags nod for nonprescription sales of the little blue pill for men in the U.K. - Fierce Pharma

OTC Viagra: Pfizer snags nod for nonprescription sales of the little blue pill for men in the U.K. Fierce Pharma

Investors left feeling blue as Cerulean admits defeat on cancer pipeline - Fierce Biotech

Investors left feeling blue as Cerulean admits defeat on cancer pipeline Fierce Biotech

Hikma set to join pharma blue-chips in UK market - Financial Times

Hikma set to join pharma blue-chips in UK market Financial Times

Top Pharmablue Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant